BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38384014)

  • 1. Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors.
    Minareci Y; Ak N; Tosun OA; Sozen H; Saip PM; Topuz S; Salihoglu MY
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S523-S529. PubMed ID: 38384014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for patients with brain metastasis from gynecological cancer: a significance of treatment-free interval of more than 6 months.
    Takeshita S; Todo Y; Furuta Y; Okamoto K; Minobe S; Yamashiro K; Kato H
    Jpn J Clin Oncol; 2017 Jul; 47(7):604-610. PubMed ID: 28398498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system metastasis from epithelial ovarian cancer- predictors of outcome.
    Jayraj AS; Kumar S; Bhatla N; Malik PS; Mathur S; Rangarajan K; Vanamail P; Thulkar S; Kumar L
    Curr Probl Cancer; 2023 Feb; 47(1):100918. PubMed ID: 36502584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.
    Liu BL; Liu SJ; Baskys A; Cheng H; Han Y; Xie C; Song H; Li J; Xin XY
    BMC Cancer; 2014 Nov; 14():829. PubMed ID: 25399490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncology.
    Seber S; Turkmen E; Harputoğlu H; Yeşil H; Arpacι E; Menekşe S; Pilancι K; Oruç Z; Taskoylu BY; Gumusay O; Aksoy A; Karaagac M; Ozarslan E; Yetisyigit T
    Eur J Gynaecol Oncol; 2017; 38(2):227-231. PubMed ID: 29953785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
    Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
    Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
    Kim HJ; Im SA; Keam B; Kim YJ; Han SW; Kim TM; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Noh DY; Heo DS; Park IA; Bang YJ; Ha SW
    J Neurooncol; 2012 Jan; 106(2):303-13. PubMed ID: 21938531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study.
    Gao X; Chen M; Liu X; Shi Y; Liang H; Zhou Q; Zhao J; Pan R; Zhong W; Xu Y; Wang M
    Front Oncol; 2022; 12():879554. PubMed ID: 35558520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
    Pectasides D; Aravantinos G; Fountzilas G; Kalofonos C; Efstathiou E; Karina M; Pavlidis N; Farmakis D; Economopoulos T; Dimopoulos MA
    Anticancer Res; 2005; 25(5):3553-8. PubMed ID: 16101179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of solitary fibrous tumors and hemangiopericytomas and risk factors related to recurrence and survival based on the 2021 WHO classification of central nervous system tumors.
    Wu Y; Zhao T; Cai Y; Zheng M; Zhang Y; Qu Y; Cai Q
    J Neurosurg; 2024 Jan; 140(1):69-79. PubMed ID: 37310060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis.
    da Costa AABA; Dos Santos ES; Cotrim DP; Pandolfi NC; Cesca MG; Mantoan H; Sanches SM; Ribeiro ARG; de Brot L; Bonvolim G; Sanematsu PI; de Souza RP; Maya JML; de Souza Castro F; da Nogueira Silveira Lima JP; Chen MJ; Guimarães APG; Baiocchi G
    BMC Cancer; 2019 Dec; 19(1):1194. PubMed ID: 31805898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors for non-small cell lung cancer patients with central nervous system metastasis with positive driver genes].
    Li R; Zhang SR; Liu XF; Zhang JW; Zhao JY; Bai P; Zhang XC
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1202-1209. PubMed ID: 37087403
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence, clinicopathological characteristics, and therapeutic strategy for gastric cancer patients with metastasis to the central nervous system.
    Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Asia Pac J Clin Oncol; 2023 Oct; 19(5):e195-e201. PubMed ID: 35791882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review.
    Cormio G; Maneo A; Parma G; Pittelli MR; Miceli MD; Bonazzi C
    Ann Oncol; 1995 Jul; 6(6):571-4. PubMed ID: 8573536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer.
    Growdon WB; Lopez-Varela E; Littell R; Oliva E; Seiden M; Krasner C; Lee H; Fuller A
    Int J Gynecol Cancer; 2008; 18(2):262-8. PubMed ID: 17587320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial Ovarian Cancer Metastatic to the Central Nervous System and a Family History Concerning for Hereditary Breast and Ovarian Cancer--A Potential Relationship.
    Jernigan AM; Mahdi H; Rose PG
    Int J Gynecol Cancer; 2015 Sep; 25(7):1232-8. PubMed ID: 26067864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
    Yang Y; Li X; Qian H; Di G; Zhou R; Dong Y; Chen W; Ren Q
    Comput Intell Neurosci; 2022; 2022():6833078. PubMed ID: 36268143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system metastases in breast cancer.
    Kiricuta IC; Kölbl O; Willner J; Bohndorf W
    J Cancer Res Clin Oncol; 1992; 118(7):542-6. PubMed ID: 1624546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Holmberg L
    Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of 25 cases of brain metastasis from gynecological cancers].
    Yuan GW; Wu LY; Huang MN; Yao HW
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):191-5. PubMed ID: 22781070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.